DDInter948 DDInter1348
Human interferon beta (165 residues), cysteine 17 is substituted with serine. Produced in E. coli, no carbohydrates, MW=18.5kD
The global prevalence of obesity is increasing rapidly. Obesity-related complications lead to significant personal and economic burden by reducing quality of life and increasing the cost of healthcare. In some individuals, diet and exercise are insufficient to maintain weight loss, and pharmacological or surgical intervention is required. Orlistat is a lipase inhibitor used in the treatment of obesity that works by inhibiting fat-metabolizing enzymes. It was approved by the FDA for use in combination with a reduced-calorie diet in 1999. This drug is a generally well-tolerated and effective weight-loss aid and is now available in both over-the-counter and prescription preparations, depending on the dosage quantity.
Orlistat {u} (Compound) resembles {v} (Compound) Ethanolamine Oleate
Orlistat {u} (Compound) resembles {v} (Compound) Sodium Tetradecyl Sulfate
Orlistat {u} (Compound) treats {v} (Disease) type 2 diabetes mellitus
Orlistat {u} (Compound) binds {v} (Gene) DAGLA
Orlistat {u} (Compound) upregulates {v} (Gene) SCD
Orlistat {u} (Compound) is included by {v} (Pharmacologic Class) Lipase Inhibitors
Orlistat {u} (Compound) downregulates {v} (Gene) AKR1B10
Orlistat {u} (Compound) causes {v} (Side Effect) Otitis
Orlistat {u} may cause a minor interaction that can limit clinical effects when taken with {v} Cholecalciferol
Orlistat {u} may cause a minor interaction that can limit clinical effects when taken with {v} Doxercalciferol
Orlistat (Compound) resembles Ethanolamine Oleate (Compound)
Orlistat (Compound) resembles Sodium Tetradecyl Sulfate (Compound)
Orlistat (Compound) treats type 2 diabetes mellitus (Disease)
Orlistat (Compound) binds DAGLA (Gene)
Orlistat (Compound) upregulates SCD (Gene)
Orlistat (Compound) is included by Lipase Inhibitors (Pharmacologic Class)
Orlistat (Compound) downregulates AKR1B10 (Gene)
Orlistat (Compound) causes Otitis (Side Effect)
Orlistat may cause a minor interaction that can limit clinical effects when taken with Cholecalciferol
Orlistat may cause a minor interaction that can limit clinical effects when taken with Doxercalciferol